Morton Drug Company dba Morton LTC – FDA 483, Aug 31, 2018
Morton Drug Company dba Morton LTC in Neenah, WI, was inspected from August 27-31, 2018, and received a Form FDA 483 with three observations. The inspection revealed significant deficiencies in aseptic processing, including inadequate cleaning procedures for beta-lactam drugs, insufficient disinfection of materials entering aseptic areas, and media fills that did not accurately simulate production operations. These issues indicate potential risks of product contamination and compromise of sterility.
ID · ab3db089-b2cc-4412-9058-533dab2e4da9
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.